Moteur de recherche d’entreprises européennes

Conseils & Astuces
Nos pages FAQ tout sur la recherche en un clic et aperçu de la recherche avancée expliquent comment utiliser notre moteur de recherche.

Financement de l’UE (1 674 240 €) : Protecting patients with enhanced susceptibility to infections Hor08/04/2016 Programme de recherche et d'innovation de l'UE « Horizon »

Texte

Protecting patients with enhanced susceptibility to infections

The Microbes in Health and Disease research programme at the University Medical Center Groningen (UMCG) proposes the Doctoral Training Programme PRONKJEWAIL (‘a real gem’) in the field of hospital care and infection. The specific training objective is ‘protecting patients with enhanced susceptibility to infections’. PRONKJEWAIL will recruit 16 international ESRs, who will be trained in research, transferable skills, and network and capacity building. They will be guided by experienced supervisors from the departments of Medical Microbiology, Internal Medicine, Intensive Care, Clinical Pharmacy and Pharmacology, Rheumatology and Immunology, Surgery, Cell Biology, and Pharmacoepidemiology and Pharmacoeconomics at the UMCG. 26 partner organisations, including 14 private sector partners, are committed to support ESR training via mentoring, courses and secondments. Research training builds on four Pillars: 1) vaccines and primary prevention; 2) personalized detection and infection prevention; 3) iatrogenic influence on the microbiome and 4) personalized therapy/stewardship. Each Pillar integrates fundamental, translational and clinical/epidemiological training projects. The high exposure to fundamental, translational and clinical research in academia and industry will increase the ESRs future problem-solving capabilities. Further, ESRs will learn to value mobility through internships at international partner organizations. By providing an excellent scientific working environment PRONKJEWAIL will directly impact on hospital care and, ultimately, it will contribute to enhanced public health. By providing excellent training, PRONKJEWAIL will develop new talent within the next generation of medical researchers thereby strengthening the European Research Area.
CHR. Hansen AS ?
ACADEMISCH ZIEKENHUIS GRONINGEN 1 674 240 €

https://cordis.europa.eu/project/id/713660
CSV export

Journalisme d'investigation

Découvre les liens internationaux des entreprises avec notre compte d'investigation gratuit

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : CHR. Hansen AS, Hørsholm, Danemark.

Creative Commons License Les visualisations de "CHR. Hansen AS - Financement de l’UE (1 674 240 €) : Protecting patients with enhanced susceptibility to infections" sont mis à disposition par North Data et peuvent être réutilisées selon les termes de la licence Creative Commons CC-BY.